MATT ABERNETHY

Insider Reports History

Location
San Diego, CA
Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MATT ABERNETHY:

Company Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Common Stock 35,810 $4,185,072 $116.87 13 Feb 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Restricted Stock Unit 6,725 $795,399 $118.28 13 Feb 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Restricted Stock Unit 8,966 $387,690 $43.24 13 Feb 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Non-Qualified Stock Option 0 $0 $73.60 13 Aug 2024 Direct
FATE THERAPEUTICS INC Director Stock Option (Right to Buy) 110,000 29 May 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Stock Option 45,538 12 Feb 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Stock Option 45,058 13 Feb 2024 Direct

Insider Reports Filed by MATT ABERNETHY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FATE FATE THERAPEUTICS INC 29 May 2025 1 $0 4 Director 30 May 2025, 16:06
FATE FATE THERAPEUTICS INC 29 May 2025 0 $0 3 Director 30 May 2025, 16:01
NBIX NEUROCRINE BIOSCIENCES INC 12 Feb 2025 8 -$298,923 4 Chief Financial Officer 14 Feb 2025, 18:00
NBIX NEUROCRINE BIOSCIENCES INC 08 Feb 2025 3 -$115,909 4 Chief Financial Officer 12 Feb 2025, 18:41
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2025 3 -$196,136 4 Chief Financial Officer 04 Feb 2025, 17:31
NBIX NEUROCRINE BIOSCIENCES INC 13 Aug 2024 3 -$1,082,587 4 Chief Financial Officer 15 Aug 2024, 17:12
NBIX NEUROCRINE BIOSCIENCES INC 16 Jul 2024 3 -$68,797 4 Chief Financial Officer 18 Jul 2024, 16:45
NBIX NEUROCRINE BIOSCIENCES INC 14 May 2024 6 -$4,138,436 4 Chief Financial Officer 16 May 2024, 16:40
NBIX NEUROCRINE BIOSCIENCES INC 13 Feb 2024 3 -$179,612 4 Chief Financial Officer 15 Feb 2024, 17:27
NBIX NEUROCRINE BIOSCIENCES INC 06 Feb 2024 2 -$313,530 4 Chief Financial Officer 08 Feb 2024, 19:12
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2024 1 -$180,539 4 Chief Financial Officer 02 Feb 2024, 19:00
NBIX NEUROCRINE BIOSCIENCES INC 21 Aug 2023 1 -$228,958 4 Chief Financial Officer 23 Aug 2023, 19:58
NBIX NEUROCRINE BIOSCIENCES INC 13 Feb 2023 2 $0 4 Chief Financial Officer 15 Feb 2023, 18:04
NBIX NEUROCRINE BIOSCIENCES INC 06 Feb 2023 5 -$2,933,470 4 Chief Financial Officer 08 Feb 2023, 18:16
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2023 1 -$141,108 4 Chief Financial Officer 02 Feb 2023, 15:53
NBIX NEUROCRINE BIOSCIENCES INC 07 Feb 2022 3 -$345,486 4 Chief Financial Officer 09 Feb 2022, 17:51
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2022 2 $0 4 Chief Financial Officer 02 Feb 2022, 18:54
NBIX NEUROCRINE BIOSCIENCES INC 01 Dec 2021 1 -$135,852 4 Chief Financial Officer 03 Dec 2021, 16:02